New York State Common Retirement Fund Larimar Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 6,619 shares of LRMR stock, worth $52,687. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,619
Previous 6,619
-0.0%
Holding current value
$52,687
Previous $48,000
10.42%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LRMR
# of Institutions
126Shares Held
67.1MCall Options Held
280KPut Options Held
76.3K-
Deerfield Management Company, L.P. (Series C) New York, NY21.2MShares$169 Million2.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$48.1 Million0.55% of portfolio
-
Janus Henderson Group PLC London, X05.57MShares$44.3 Million0.02% of portfolio
-
Goldman Sachs Group Inc New York, NY4.25MShares$33.8 Million0.0% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.17MShares$33.2 Million9.0% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $344M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...